MicroRNA-21 expression is associated with overall survival in patients with glioma.

MicroRNA-21 expression is associated with overall survival in patients with glioma.
复制标题

DOI:
10.1186/1746-1596-8-200
复制
发表时间:
2013-12-10
影响因子:
2.6
通讯作者:
Zhang Z
Zhang Z
中科院分区:
医学4区
文献类型:
--
作者:
Wu L;Li G;Feng D;Qin H;Gong L;Zhang J;Zhang Z

文献摘要

参考文献

被引文献

相似文献

MicroRNA-21已被证实与胶质瘤的增殖和侵袭相关;因此,我们试图阐明miR-21在WHO I至IV级胶质瘤组织中表达的临床价值。使用实时PCR评价了152对人脑胶质瘤和非肿瘤性脑组织。同时分析miR-21表达与胶质瘤患者临床病理因素及预后的关系。在本研究中,使用Kaplan-Meier方法和考克斯比例风险模型进行生存分析。miR-21在胶质瘤组织中的表达显著高于相应的非肿瘤脑组织(P < 0.001)。这种观察到的高miR-21表达与胶质瘤患者的高病理分级和Karnofsky表现评分显著相关。此外,低miR-21表达患者的总体生存期显著长于高miR-21表达患者(P < 0.001)。多因素考克斯回归分析显示miR-21可能是胶质瘤患者生存的独立预后指标。我们的数据表明,miR-21可能是胶质瘤,特别是那些高病理分级的胶质瘤的候选独立标志物,这也可能是一个潜在的治疗靶点的分子胶质瘤治疗。本文的虚拟幻灯片可以在这里找到:http://www.diagnosticpathology.diagnomx.eu/vs/1445749171109834。
MicroRNA-21 has been proved to be associated with glioma proliferation and invasion; thus, we sought to clarify the clinical value of miR-21 expression in glioma tissues with WHO grade I to IV. One hundred and fifty-two pairs of human gliomas and non-neoplastic brain tissues were evaluated using real-time PCR. The association of miR-21 expression with clinicopathological factors or the prognosis of glioma patients was also analyzed. In this study, survival analysis was performed using the Kaplan-Meier method and Cox’s proportional hazards model. MiR-21 was more greatly expressed in glioma tissues compared to the corresponding non-neoplastic brain tissues (P < 0.001). This observed high miR-21 expression was significantly associated with high pathological grades and the Karnofsky performance score of glioma patients. In addition, overall patient survival for those with low miR-21 expression was significantly longer than those patients with high miR-21 expression (P < 0.001). Moreover, multivariate Cox regression analysis indicated that miR-21 might be an independent prognostic marker for glioma patient survival. Our data show that miR-21 may be a candidate independent marker for gliomas, especially those with high pathological grades, and this could also be a potential therapeutic target for molecular glioma therapy. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1445749171109834.
DOI: 10.1186/1748-717x-8-146
发表时间: 2013-06-19
期刊: Radiation oncology (London, England)
影响因子: --
作者:
Wang XC;Wang W;Zhang ZB;Zhao J;Tan XG;Luo JC
通讯作者: Luo JC
DOI: 10.1371/journal.pone.0061622
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Sanchez-Diaz PC;Hsiao TH;Chang JC;Yue D;Tan MC;Chen HI;Tomlinson GE;Huang Y;Chen Y;Hung JY
通讯作者: Hung JY
DOI: 10.1016/j.cca.2010.02.074
发表时间: 2010-06-03
影响因子: 5
作者:
Zhang, Ji-guang;Wang, Jian-jun;Yang, Guang-hai
通讯作者: Yang, Guang-hai
血清 miRNA-21:转移性激素难治性前列腺癌患者的水平升高以及多西紫杉醇化疗疗效的潜在预测因素
DOI: 10.1002/pros.21246
发表时间: 2011-02-15
期刊: PROSTATE
影响因子: 2.8
作者:
Zhang, Hai-Liang;Yang, Li-Feng;Ye, Ding-Wei
通讯作者: Ye, Ding-Wei
DOI: 10.1074/jbc.m111.285098
发表时间: 2011-11-11
影响因子: 4.8
作者:
Yang, Chuan He;Yue, Junming;Pfeffer, Lawrence M.
通讯作者: Pfeffer, Lawrence M.